Leucine Rich Repeat Transmembrane Neuronal 3 (LRRTM3)
The deduced 513-amino acid protein contains an N-terminal signal sequence, followed by 10 extracellular LRRs flanked by cysteine-rich domains, a transmembrane region, and an intracellular tail. LRRTM3 has 3 N-glycosylation sites, several putative phosphorylation sites, and a C terminus that ends in the sequence ECEV, which is a characteristic of LRRTM family members. RT-PCR analysis of human tissues detected LRRTM3 expression restricted to whole brain, including amygdala, caudate nucleus, cerebellum, corpus callosum, hippocampus, and thalamus. In developing mice, Lrrtm3 was expressed at embryonic day 13 and 15, reaching highest levels at postnatal day 1 that persisted into adulthood. In situ hybridization of adult mouse brain detected widespread Lrrtm3 expression predominantly in neurons.
Organism species: Homo sapiens (Human)
- Customized Service n/a Recombinant Leucine Rich Repeat Transmembrane Neuronal 3 (LRRTM3) Recombinant Protein Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Leucine Rich Repeat Transmembrane Neuronal 3 (LRRTM3) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Leucine Rich Repeat Transmembrane Neuronal 3 (LRRTM3) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Leucine Rich Repeat Transmembrane Neuronal 3 (LRRTM3) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Leucine Rich Repeat Transmembrane Neuronal 3 (LRRTM3) ELISA Kit Customized Service Offer
